Imperial Ginseng Products (IGPFF) 15-12G Securities registration termination

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File No. 0-25026

Imperial Ginseng Products Ltd.

(Exact name of registrant as specified in its charter)

650 Georgia Street, Suite 1601

Vancouver, British Columbia

Canada, V6B 4N7
(604) 689-8863

(Address, including zip code and telephone number, including
 area code, of principal executive offices)

Common Stock Without Par Value

(Title of each class of securities covered by this Form)

None

(Title of all other classes of securities for which a duty
to file reports under Section 13(a) or 15(d) remains)

________________

                Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to
terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)(i)	o	Rule 12h-3(b)(1)(i)	o
Rule 12g-4(a)(1)(ii)	o	Rule 12h-3(b)(1)(ii)	o
Rule 12g-4(a)(2)(i)	ý	Rule 12h-3(b)(2)(i)	ý
Rule 12g-4(a)(2)(ii)	o	Rule 12h-3(b)(2)(ii)	o
		Rule 15d-6	o

Approximate number of holders of record as of the certification or notice date:  256.

101347.3 1562.000

                Pursuant to the requirements of the Securities Exchange Act of 1934, Imperial Ginseng Products Ltd.

has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

August 23, 2004

    Imperial Ginseng Products Ltd.

By:	/s/ JAMES CHANG
	James Chang
	President and Chief Executive Officer

2

101347.3 1562.000